Loading clinical trials...
Loading clinical trials...
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma: Comparison of Two Established Schedules
Conditions
Interventions
Radiation Therapy
Temozolomide Oral Product
Locations
1
United States
University of Pittsburgh Medical Center, Radiation Oncology
Pittsburgh, Pennsylvania, United States
Start Date
December 14, 2021
Primary Completion Date
December 1, 2026
Completion Date
July 1, 2027
Last Updated
June 18, 2025
NCT05969860
NCT02800486
NCT05789394
NCT06934889
NCT05283330
NCT00083512
Lead Sponsor
John Flickinger
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions